<?xml version="1.0" encoding="UTF-8"?>
<svg height="813.2" width="537.5" xmlns="http://www.w3.org/2000/svg">
 <g>
  <text svgx:width="0.61,0.61,0.67,0.56,0.33,0.25,0.44,0.5,0.5,0.39,0.5,0.5,0.28,0.25,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.5,0.25,0.33,0.5,0.5,0.67,0.25,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.25" y="44.8" x="315.6,321.4,327.2,333.5,338.8,342.0,344.4,348.6,353.3,358.1,361.7,366.5,371.2,373.9,376.3,381.1,385.8,390.6,395.3,398.5,403.2,408.0,411.1,415.9,420.6,425.3,430.1,433.3,438.1,442.8,447.6,452.3,454.7,459.5,461.9,465.0,469.8,474.5,480.8,483.2,488.0,492.8,497.5,502.3,505.4,510.2,514.9,519.7,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">EXCLI Journal 2017;16:1103-1113 – ISSN 1611-2156 </text>
  <text svgx:width="0.61,0.44,0.44,0.44,0.28,0.44,0.44,0.5" y="55.7" x="217.3,223.1,227.3,231.5,235.7,238.4,242.6,246.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Received</text>
  <text svgx:width="0.28" y="55.7" x="251.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.44,0.5,0.5,0.44,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.44,0.44,0.44,0.5,0.28,0.44,0.5" y="55.7" x="254.2,256.6,260.8,265.5,270.3,274.5,276.9,281.7,286.4,288.8,291.2,295.9,300.7,305.4,310.2,312.6,315.0,319.7,323.9,328.1,332.4,337.1,339.8,344.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> June 26, 2017, accepted</text>
  <text svgx:width="0.28" y="55.7" x="348.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.61,0.5,0.5,0.5,0.39,0.28,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.28,0.28,0.39,0.5,0.44,0.5" y="55.7" x="351.2,353.6,359.4,364.2,368.9,373.7,377.4,380.0,382.4,387.2,391.9,394.3,396.7,401.4,406.2,410.9,415.7,418.0,420.4,425.2,429.9,434.7,437.3,440.0,443.6,448.4,452.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> August 17, 2017, published</text>
  <text svgx:width="0.28" y="55.7" x="457.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.61,0.5,0.5,0.5,0.39,0.28,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25" y="55.7" x="460.0,462.4,468.2,473.0,477.7,482.5,486.1,488.8,491.2,495.9,500.7,503.1,505.5,510.2,514.9,519.7,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> August 29, 2017 </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.25" y="803.2" x="285.7,291.7,297.7,303.7,309.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1110 </text>
  <text svgx:width="0.44,0.5,0.5,0.25,0.55,0.5,0.5,0.33,0.5,0.5,0.28,0.25,0.55,0.44,0.44,0.44,0.28,0.44,0.28,0.44,0.25,0.25,0.55,0.5,0.44,0.5,0.44,0.25,0.55,0.25,0.55,0.5,0.44,0.44,0.5,0.25,0.55,0.39,0.5,0.5,0.72,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.33" y="96.1" x="70.9,76.3,82.3,88.3,91.3,92.3,98.3,104.3,108.3,114.3,120.3,123.6,126.6,127.7,133.0,138.3,143.7,147.0,152.3,155.7,161.0,164.0,167.0,168.0,174.0,179.3,185.3,190.6,193.6,194.6,197.6,198.6,204.6,210.0,215.3,221.2,224.2,225.2,229.9,235.9,241.9,250.5,256.5,259.5,260.5,263.9,269.9,272.9,273.9,279.2,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and bornyl acetate, have been shown to ex-</text>
  <text svgx:width="0.5,0.28,0.5,0.28,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.28,0.44,0.39,0.25,0.55,0.33,0.67,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25" y="109.9" x="70.9,76.9,80.3,86.3,89.6,93.0,96.0,97.7,103.0,109.0,112.4,115.7,119.7,123.1,129.0,133.0,136.3,141.6,151.0,160.3,165.7,169.0,175.0,179.0,185.0,188.0,189.8,195.1,200.5,203.8,207.2,213.1,216.4,219.8,223.1,228.5,233.2,236.2,237.9,241.9,249.8,255.8,261.2,267.2,270.2,271.9,277.3,283.3,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">hibit anti-inflammatory activities (Chen and </text>
  <text svgx:width="0.72,0.28,0.28,0.28,0.5,0.44,0.5,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.5,0.18,0.72,0.28,0.44,0.39,0.39,0.28,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.67,0.5,0.33,0.28,0.5,0.5,0.25" y="123.7" x="70.9,79.6,82.9,86.3,89.6,95.6,101.0,107.0,110.0,113.0,113.9,119.9,125.9,131.9,137.9,141.2,144.2,145.2,151.2,153.3,162.0,165.3,170.6,175.3,180.0,183.3,189.3,192.3,193.3,198.6,202.0,205.0,205.9,211.3,214.6,217.6,220.6,223.6,224.6,230.6,236.6,242.6,248.5,251.9,254.9,255.8,263.8,269.9,273.9,277.2,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Viljoen, 2010; d'Alessio et al., 2013; Rufino </text>
  <text svgx:width="0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.25,0.94,0.5,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.61,0.5,0.44,0.33,0.44,0.33,0.5,0.33,0.44,0.25,0.25" y="137.5" x="70.9,76.3,79.6,81.9,87.3,90.6,93.6,96.6,98.9,104.9,111.0,117.0,123.0,126.0,128.3,134.3,140.3,146.3,152.3,155.7,158.0,169.2,175.2,177.5,182.9,186.2,188.6,193.9,197.2,200.2,203.2,205.6,211.6,217.6,223.6,229.6,233.6,236.6,238.9,246.2,252.2,257.5,261.5,266.9,270.9,276.9,280.9,286.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">et al., 2014, 2015; Wu et al., 2004). Therefore, </text>
  <text svgx:width="0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.61,0.72,0.25,0.55,0.44,0.5,0.5,0.28,0.5,0.25" y="151.3" x="70.9,74.3,80.3,85.6,88.6,89.7,95.0,101.0,104.3,107.7,111.6,115.0,121.0,125.0,128.3,133.6,143.0,152.3,157.6,161.0,167.0,171.0,177.0,180.0,181.1,186.4,191.7,195.1,198.4,204.4,207.7,211.1,217.1,220.1,221.2,227.2,231.1,234.1,235.2,242.5,249.8,258.5,261.5,262.6,267.9,273.9,279.9,283.3,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">the anti-inflammatory activity of LEO could </text>
  <text svgx:width="0.5,0.44,0.25,0.44,0.28,0.28,0.33,0.28,0.5,0.5,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.28,0.39,0.25,0.78,0.44,0.28,0.5,0.33,0.25,0.44,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.25,0.44,0.25,0.39,0.5,0.5,0.33" y="165.1" x="70.9,76.9,82.3,84.6,90.0,93.3,96.7,100.6,104.0,110.0,116.0,119.3,124.7,130.6,133.0,136.3,142.4,144.7,148.1,151.4,156.0,158.4,167.7,173.0,176.4,182.4,186.4,188.7,194.1,200.1,206.1,210.8,214.1,217.5,220.8,226.8,232.2,238.2,241.5,246.2,248.6,254.6,258.6,261.0,266.3,268.6,273.3,279.3,285.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">be attributed to its major constituents or a syn-</text>
  <text svgx:width="0.44,0.33,0.5,0.44,0.28,0.28,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.78,0.5,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25" y="178.9" x="70.9,76.3,80.3,86.3,91.6,94.9,98.3,103.6,107.0,112.3,117.7,121.0,124.4,130.4,136.4,139.8,145.1,154.3,160.3,166.3,172.4,175.8,179.1,185.1,190.4,193.8,199.1,205.1,211.1,215.8,219.1,222.5,225.8,231.8,237.1,243.1,246.5,251.2,254.6,260.6,264.6,269.9,274.6,279.9,285.9,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ergetic action among the constituents present </text>
  <text svgx:width="0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.28,0.28,0.25,0.25" y="192.7" x="70.9,74.3,80.3,83.3,86.6,92.7,98.0,101.0,106.9,110.3,113.6,116.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">in the oil. </text>
  <text svgx:width="0.89,0.44,0.44,0.33,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.25,0.55,0.61,0.56,0.56,0.25,0.55,0.5,0.33,0.5,0.33" y="206.5" x="88.8,99.5,104.8,110.1,114.1,120.1,126.1,132.1,137.5,143.5,148.8,153.5,156.5,158.5,163.8,167.8,173.1,176.1,178.2,183.5,188.8,192.2,195.5,201.5,206.8,210.2,215.5,221.5,224.5,226.5,232.5,238.5,241.5,243.6,250.9,257.6,264.2,267.2,269.3,275.3,279.3,285.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Macrophages are activated by LPS pro-</text>
  <text svgx:width="0.5,0.5,0.44,0.44,0.25,0.55,0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.33,0.44,0.44,0.28,0.5,0.33,0.39,0.25,0.25,0.55,0.39,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.72,0.72,0.25,0.25" y="220.3" x="70.9,76.9,82.9,88.3,93.6,96.6,98.1,104.1,108.1,114.1,118.1,121.4,127.4,131.3,134.7,140.0,149.4,158.6,164.0,167.3,173.3,177.3,183.3,186.3,187.8,191.8,197.1,202.5,205.8,211.8,215.8,220.5,223.5,226.5,228.0,232.6,238.6,244.0,249.9,252.9,254.4,259.7,264.4,267.4,268.8,277.5,286.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">duce pro-inflammatory factors, such as NO, </text>
  <text svgx:width="0.56,0.72,0.61" y="234.1" x="70.9,77.6,86.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">PGE</text>
  <text svgx:width="0.5" y="234.5" x="93.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2</text>
  <text svgx:width="0.25,0.25,0.55,0.28,0.72,0.72,0.56,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.72,0.72,0.33,0.5,0.25,0.55,0.33,0.72,0.5,0.33,0.5,0.5,0.5,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25" y="234.1" x="97.6,100.6,103.6,105.6,108.9,117.6,126.3,132.9,136.0,139.0,141.0,146.3,152.3,158.3,161.3,163.4,171.4,180.0,188.7,192.7,198.7,201.7,203.7,207.7,216.4,222.4,226.4,232.4,238.4,244.4,249.7,255.8,258.8,260.8,266.1,269.5,272.5,274.5,279.8,283.2,286.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, iNOS, and COX-2 (Korhonen et al., </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.56,0.5,0.33,0.25,0.28,0.5,0.28,0.39,0.25,0.33,0.44,0.44,0.39,0.5,0.5,0.25,0.25,0.72,0.44,0.25,0.39,0.44,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.61,0.56,0.56,0.25,0.44,0.39,0.25,0.44,0.5,0.25" y="247.9" x="70.9,76.9,82.9,88.9,94.9,98.9,102.0,105.0,111.7,117.7,121.7,124.7,128.0,134.0,137.4,142.1,145.1,149.1,154.4,159.8,164.4,170.4,176.4,179.5,182.5,191.2,196.5,199.4,204.1,209.4,212.8,218.1,223.4,226.8,232.1,238.1,241.2,248.5,255.2,261.8,264.9,270.2,274.9,277.9,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2005). For this reason, we selected LPS as an </text>
  <text svgx:width="0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.5,0.28,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.55,0.61,0.5,0.44,0.25" y="261.7" x="70.9,74.3,80.3,84.3,87.6,92.9,102.3,111.5,116.8,120.2,126.2,130.3,136.3,139.3,142.7,147.4,150.7,154.0,163.3,169.3,172.6,177.9,183.9,187.3,190.3,193.7,197.7,203.7,207.7,210.7,214.1,217.4,223.4,228.8,231.8,235.2,239.9,243.2,249.2,255.2,261.2,264.2,267.2,270.6,278.0,284.0,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">inflammatory stimulant for the study. The </text>
  <text svgx:width="0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.72,0.72,0.25,0.5,0.5,0.25,0.28,0.72,0.72,0.56,0.25,0.5,0.5,0.44,0.25,0.28,0.5,0.25,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25" y="275.5" x="70.9,76.9,80.9,86.9,92.9,98.9,104.3,107.6,110.9,116.9,123.0,125.7,131.7,135.7,138.4,147.0,155.7,158.4,164.4,170.4,173.1,176.4,185.1,193.8,200.4,203.1,209.2,215.2,220.5,223.2,226.5,232.5,235.2,239.9,243.2,246.6,255.8,261.8,265.2,270.5,273.8,277.2,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">production of NO by iNOS due to stimulation </text>
  <text svgx:width="0.72,0.28,0.28,0.5,0.25,0.55,0.61,0.56,0.56,0.25,0.55,0.5,0.28,0.44,0.5,0.39,0.25,0.55,0.44,0.5,0.25,0.55,0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25,0.55,0.33,0.5,0.28,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.33" y="289.3" x="70.9,79.6,82.9,86.3,92.3,95.3,96.6,103.9,110.6,117.3,120.3,121.5,127.5,130.9,136.2,142.2,146.9,149.9,151.2,156.5,162.4,165.4,166.7,170.0,179.3,185.3,191.3,195.3,198.7,204.0,209.9,213.3,216.3,217.6,221.6,227.5,230.8,236.1,239.1,240.4,243.7,249.7,252.7,253.9,257.3,263.3,267.3,270.6,276.0,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">with LPS plays an important role in inflam-</text>
  <text svgx:width="0.78,0.44,0.28,0.28,0.5,0.5,0.25,0.33,0.89,0.44,0.67,0.44,0.5,0.5,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.56,0.28,0.78,0.28,0.28,0.44,0.33,0.25,0.28,0.5,0.25,0.72,0.72,0.25,0.25" y="303.1" x="70.9,80.2,85.5,88.9,92.2,98.2,104.2,107.1,111.1,121.8,127.1,135.1,140.5,146.5,152.5,155.4,160.7,164.1,166.9,172.3,175.6,178.6,181.6,184.5,190.5,196.5,202.5,208.6,212.6,215.6,218.4,225.1,228.5,237.7,241.1,244.4,249.7,253.8,256.6,260.0,266.0,268.9,277.5,286.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">mation (McCann et al., 2005). Similar to NO, </text>
  <text svgx:width="0.56,0.72,0.61" y="316.9" x="70.9,77.6,86.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">PGE</text>
  <text svgx:width="0.5" y="317.3" x="93.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2</text>
  <text svgx:width="0.25,0.28,0.39,0.25,0.44,0.5,0.25,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.33,0.25,0.5,0.44,0.5,0.44,0.33,0.44,0.28,0.44,0.5,0.25" y="316.9" x="97.6,101.1,104.4,109.1,112.6,118.0,124.0,127.5,130.8,136.8,140.8,144.2,149.5,158.9,168.2,173.5,176.9,182.9,186.9,192.9,196.4,205.7,211.0,217.0,220.3,225.7,229.0,235.0,239.0,242.5,248.6,253.9,259.9,265.2,269.2,274.6,277.9,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> is an inflammatory mediator generated </text>
  <text svgx:width="0.44,0.28,0.25,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.39,0.28,0.28,0.44,0.39,0.25,0.5,0.5,0.25,0.67,0.72,0.72,0.33,0.5,0.25,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.28,0.39,0.25,0.28,0.5,0.33" y="330.7" x="70.9,76.3,79.6,82.7,86.1,92.1,96.0,99.4,104.7,114.1,123.3,128.7,132.0,138.0,142.0,148.0,151.2,155.8,159.2,162.5,167.8,172.5,175.6,181.6,187.6,190.8,198.8,207.4,216.1,220.1,226.1,229.1,232.3,240.9,246.9,250.3,255.6,261.6,264.8,268.1,272.8,275.9,279.3,285.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">at inflammatory sites by COX-2, which is in-</text>
  <text svgx:width="0.5,0.5,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.44,0.28,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.78,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.33,0.5,0.5,0.28,0.44,0.25" y="344.5" x="70.9,76.9,82.9,86.3,92.3,97.6,103.6,106.6,108.1,111.4,117.4,120.4,121.9,125.3,131.3,136.6,139.6,141.1,147.1,152.4,155.8,161.8,167.8,173.8,179.1,185.1,190.4,195.1,198.4,203.1,206.1,207.6,213.6,217.6,220.6,222.1,231.3,236.7,242.7,248.7,251.7,253.2,258.5,264.5,268.5,274.5,280.5,283.9,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">volved in the pathogenesis of many chronic </text>
  <text svgx:width="0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.25,0.55,0.39,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.33,0.5,0.44,0.5,0.78,0.44,0.28,0.5,0.28,0.5,0.25" y="358.3" x="70.9,74.3,80.3,84.3,87.6,93.0,102.3,111.6,116.9,120.2,126.3,130.3,136.3,139.3,142.3,148.3,151.7,156.3,161.7,167.0,171.6,177.0,181.7,184.7,187.7,190.6,195.3,201.3,206.7,212.7,215.7,218.7,224.0,228.7,231.7,234.7,238.7,244.6,250.0,256.0,265.2,270.5,273.9,279.9,283.2,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">inflammatory diseases, such as rheumatoid </text>
  <text svgx:width="0.44,0.33,0.28,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.25,0.55,0.44,0.44,0.5,0.44,0.44,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.44,0.33,0.5,0.28,0.5,0.5,0.44,0.39,0.44,0.5,0.28,0.44,0.33,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.25" y="372.1" x="70.9,76.3,80.3,83.6,89.6,93.6,96.9,100.3,103.6,108.3,111.3,114.3,116.7,122.0,127.4,133.4,138.7,144.0,148.0,151.0,154.0,156.4,161.8,167.8,173.8,176.8,179.2,184.5,189.8,193.8,199.8,203.2,209.2,215.2,220.5,225.2,230.5,236.5,239.9,245.2,249.2,252.2,254.6,260.6,263.9,268.6,273.9,279.3,283.9,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">arthritis, cancer, and cardiovascular disease </text>
  <text svgx:width="0.33,0.61,0.28,0.5,0.39,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.25,0.67,0.5,0.44,0.44,0.44,0.25,0.44,0.5,0.5,0.25,0.56,0.28,0.28,0.44,0.72,0.44,0.33,0.44,0.28,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25" y="385.9" x="70.9,74.9,82.3,85.6,91.6,96.3,102.3,108.3,111.3,114.9,120.9,126.8,132.8,138.8,142.1,145.7,153.7,159.7,165.1,170.4,175.7,179.3,184.7,190.7,196.7,200.3,206.9,210.3,213.6,218.9,227.6,232.9,236.9,242.3,245.6,251.6,254.6,258.2,264.2,270.2,276.2,282.2,286.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">(Lipsky, 1999; Rocca and FitzGerald, 2002). </text>
  <text svgx:width="0.61,0.5,0.5,0.39,0.25,0.25,0.33,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.44,0.5,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.72,0.72,0.25,0.25,0.56,0.72,0.61" y="399.7" x="70.9,78.3,84.3,90.3,94.9,97.9,100.3,104.3,109.6,115.6,121.6,126.9,130.3,136.3,142.3,144.6,147.9,153.9,159.3,161.6,164.9,170.2,176.2,181.5,184.8,189.5,191.8,197.8,201.8,204.1,212.8,221.5,224.4,226.8,233.4,242.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Thus, reducing the levels of NO, PGE</text>
  <text svgx:width="0.5" y="400.1" x="249.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2</text>
  <text svgx:width="0.25,0.25,0.28,0.72,0.72,0.56,0.25,0.25" y="399.7" x="253.5,256.5,258.8,262.2,270.8,279.5,286.1,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, iNOS, </text>
  <text svgx:width="0.44,0.5,0.5,0.25,0.55,0.67,0.72,0.72,0.33,0.5,0.25,0.55,0.78,0.44,0.5,0.25,0.55,0.5,0.44,0.25,0.55,0.44,0.5,0.25,0.55,0.44,0.28,0.28,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.55,0.28,0.44,0.33,0.5,0.44,0.28,0.25,0.55,0.33,0.5,0.33,0.25" y="413.5" x="70.9,76.2,82.3,88.3,91.3,93.5,101.5,110.1,118.8,122.8,128.8,131.8,134.0,143.2,148.6,154.6,157.6,159.8,165.8,171.1,174.1,176.3,181.7,187.6,190.6,192.8,198.2,201.5,204.8,208.8,214.2,219.5,222.8,226.2,232.1,237.4,240.4,242.6,246.0,251.3,255.3,261.3,266.6,270.0,273.0,275.2,279.2,285.2,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and COX-2 may be an attractive target for </text>
  <text svgx:width="0.44,0.5,0.5,0.33,0.28,0.33,0.78,0.28,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.44,0.5,0.33" y="427.3" x="70.9,76.3,82.3,88.3,92.3,95.6,99.6,108.8,112.2,118.2,124.2,127.2,128.6,133.9,139.9,143.2,146.6,150.6,153.9,159.9,163.9,167.3,172.6,181.9,191.2,196.5,199.9,205.9,209.9,215.9,218.9,220.2,225.5,229.5,233.5,238.9,244.2,247.5,252.2,255.2,258.2,259.5,263.5,269.6,272.6,273.9,279.2,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">confirming anti-inflammatory effects. In ad-</text>
  <text svgx:width="0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.33,0.61,0.33,0.5,0.51,0.25,0.25" y="441.1" x="70.9,76.9,80.3,83.6,86.9,93.0,99.0,102.0,104.7,108.0,114.0,119.3,122.0,128.0,132.0,138.1,142.1,145.4,151.4,155.4,158.7,164.1,173.4,182.7,188.0,191.4,197.4,201.4,207.4,210.1,215.5,221.5,224.8,230.8,236.8,240.2,246.2,251.5,256.2,258.9,262.9,270.2,274.2,280.1,286.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">dition, the pro-inflammatory cytokines IL-1β, </text>
  <text svgx:width="0.33,0.61,0.33,0.5,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.61,0.72,0.56,0.33,0.52,0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.5,0.72,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.33,0.28,0.5,0.5,0.28,0.44,0.25,0.55,0.28,0.5,0.25" y="454.9" x="70.9,74.9,82.3,86.3,92.3,95.3,98.3,99.4,104.7,110.7,116.7,119.7,120.9,128.1,136.8,143.4,147.5,153.8,156.8,157.9,163.3,167.3,172.6,175.6,176.7,182.7,188.7,194.7,203.4,209.4,212.4,213.6,216.9,222.9,225.9,227.0,232.4,238.4,244.4,247.7,251.7,255.1,261.1,267.1,270.4,275.7,278.7,279.9,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">IL-6, and TNF-α are known to contribute to </text>
  <text svgx:width="0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.25,0.39,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.5,0.5,0.28,0.78,0.5,0.5,0.44,0.33,0.5,0.25,0.33,0.28,0.33" y="468.7" x="70.9,74.3,80.3,84.3,87.6,93.0,102.3,111.6,116.9,120.2,126.3,130.3,136.3,139.4,145.4,148.7,153.4,158.8,164.1,168.8,174.1,178.8,181.8,184.9,189.5,195.5,200.9,206.9,210.0,215.3,220.0,223.0,229.0,235.0,238.4,247.6,253.6,259.7,265.0,269.0,275.0,278.1,282.1,285.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">inflammatory diseases, such as pulmonary fi-</text>
  <text svgx:width="0.5,0.33,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.44,0.28,0.5,0.44,0.33,0.5,0.39,0.44,0.28,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.44,0.5,0.33,0.5,0.5,0.28,0.44,0.25,0.55,0.5,0.44,0.5,0.44,0.28,0.28,0.28,0.28,0.39,0.25,0.25" y="482.5" x="70.9,76.9,80.9,86.9,91.6,94.9,99.6,102.6,105.6,113.5,118.8,122.1,128.1,133.5,137.5,143.5,148.1,153.5,156.8,162.1,166.1,172.1,176.8,180.2,184.8,187.8,190.8,198.7,204.0,210.0,214.0,220.0,226.0,229.3,234.7,237.7,245.5,251.5,256.9,262.9,268.2,271.5,274.9,278.2,281.5,286.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">brosis, atherosclerosis, chronic hepatitis, </text>
  <text svgx:width="0.33,0.5,0.44,0.5,0.78,0.44,0.28,0.5,0.28,0.5,0.25,0.55,0.44,0.33,0.28,0.5,0.33,0.28,0.28,0.28,0.39,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.5,0.33,0.44,0.28,0.5,0.25" y="496.3" x="70.9,74.9,80.9,86.3,92.3,101.5,106.9,110.2,116.2,119.6,125.6,128.6,129.6,134.9,138.9,142.3,148.3,152.2,155.6,159.0,162.3,167.0,170.0,173.0,174.0,179.3,185.3,191.3,194.3,195.3,198.6,204.6,208.6,211.9,217.3,226.6,235.9,241.2,244.6,250.6,254.6,260.6,263.6,264.6,270.6,274.6,279.9,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">rheumatoid arthritis, and inflammatory brain </text>
  <text svgx:width="0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25,0.55,0.33,0.67,0.5,0.5,0.5,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.72,0.44,0.5,0.44,0.44,0.25,0.25,0.55,0.72,0.44,0.25" y="510.1" x="70.9,76.9,80.3,84.9,90.2,95.6,100.2,105.6,110.2,113.2,117.1,121.1,129.0,135.0,141.0,147.0,153.0,156.0,159.8,165.2,168.5,171.5,175.3,180.7,184.0,187.0,190.0,193.0,196.8,202.8,208.8,214.8,220.8,224.8,227.8,230.8,234.7,243.3,248.6,254.6,260.0,265.3,268.3,271.3,275.1,283.8,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">diseases (Chung et al., 2007). Hence, we </text>
  <text svgx:width="0.78,0.44,0.44,0.39,0.5,0.33,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.61,0.72,0.25,0.55,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.33" y="523.9" x="70.9,80.2,85.5,90.8,95.5,101.5,105.5,110.9,116.9,119.9,121.2,124.5,130.6,135.9,138.9,140.2,145.6,149.6,153.6,158.9,164.2,167.6,172.3,175.3,176.6,182.6,186.6,189.6,190.9,198.3,205.6,214.3,217.3,218.6,224.6,230.6,233.6,235.0,238.3,244.3,249.6,252.6,254.0,259.3,265.3,271.3,275.3,280.7,285.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">measured the effects of LEO on the expres-</text>
  <text svgx:width="0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.72,0.72,0.56,0.25,0.44,0.5,0.5,0.25,0.67,0.72,0.72,0.33,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25" y="537.7" x="70.9,75.6,78.9,84.9,90.9,94.4,100.4,104.4,107.9,111.2,119.9,128.5,135.2,138.7,144.0,150.0,156.0,159.5,167.5,176.1,184.8,188.8,194.8,198.3,203.6,209.6,215.6,219.1,222.4,228.4,233.7,237.2,243.2,247.2,253.2,259.2,265.2,270.5,273.9,277.2,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">sion of iNOS and COX-2 and the production </text>
  <text svgx:width="0.5,0.33,0.25,0.72,0.72,0.25,0.25,0.56,0.72,0.61" y="551.5" x="70.9,76.9,80.9,84.5,93.1,101.8,104.8,108.3,115.0,123.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">of NO, PGE</text>
  <text svgx:width="0.5" y="551.9" x="131.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2</text>
  <text svgx:width="0.25,0.25,0.33,0.61,0.33,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.61,0.72,0.56,0.33,0.52,0.25,0.28,0.5,0.25,0.61,0.56,0.56,0.33,0.39,0.28,0.28,0.78,0.33" y="551.5" x="135.1,138.1,141.6,145.6,152.9,156.9,162.9,165.9,169.5,174.8,180.8,186.8,190.3,197.7,206.3,213.0,217.0,223.3,226.9,230.2,236.2,239.8,247.1,253.8,260.5,264.5,269.2,272.5,275.9,285.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, IL-6, and TNF-α in LPS-stim-</text>
  <text svgx:width="0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.67,0.72,0.94,0.5,0.5,0.5,0.25,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.55,0.56,0.33,0.44,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25" y="565.3" x="70.9,76.9,80.2,85.6,88.9,94.2,100.2,103.2,104.8,112.8,121.5,132.8,138.8,144.8,150.8,153.8,159.8,162.8,164.4,169.8,175.1,178.4,181.7,186.4,189.4,192.4,194.0,200.7,204.7,210.0,213.4,217.4,222.7,228.0,231.4,240.7,246.0,252.0,255.3,258.3,260.0,266.0,270.0,273.0,274.6,277.9,283.9,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ulated RAW264.7 cells. Pretreatment of the </text>
  <text svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.61,0.61,0.72,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" y="579.1" x="70.9,76.2,81.6,84.9,88.2,92.9,95.9,98.3,107.0,110.3,113.6,119.6,122.6,125.0,132.3,139.7,148.3,151.3,153.7,157.1,163.1,169.1,172.4,178.4,181.7,185.1,190.4,196.4,199.4,201.8,205.1,211.1,216.4,219.4,221.8,227.8,231.8,237.8,243.8,249.8,255.1,258.5,261.8,267.8,273.8,276.8,279.2,285.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">cells with LEO inhibited the production of </text>
  <text svgx:width="0.72,0.72,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.56,0.72,0.61" y="592.9" x="70.9,79.6,88.3,91.3,92.4,97.7,103.7,109.7,112.7,113.9,120.5,129.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">NO and PGE</text>
  <text svgx:width="0.5" y="593.3" x="136.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2</text>
  <text svgx:width="0.25,0.55,0.5,0.5,0.25,0.55,0.33,0.44,0.5,0.5,0.44,0.28,0.5,0.5,0.25,0.55,0.61,0.56,0.56,0.33,0.28,0.5,0.5,0.5,0.44,0.44,0.5,0.25,0.55,0.44,0.5,0.33" y="592.9" x="140.6,143.6,144.7,150.7,156.7,159.7,160.9,164.9,170.2,176.2,182.2,187.5,190.9,196.9,202.9,205.9,207.0,214.4,221.1,227.7,231.7,235.1,241.1,247.1,253.1,258.4,263.7,269.8,272.8,273.9,279.2,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> by reducing LPS-induced ex-</text>
  <text svgx:width="0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.72,0.72,0.56,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.72,0.72,0.33,0.5,0.25,0.25,0.55,0.89,0.5,0.33,0.44,0.5,0.5,0.44,0.33,0.25,0.25" y="606.7" x="70.9,76.9,80.9,86.3,90.9,95.6,98.9,105.0,111.0,114.0,117.9,123.9,127.9,130.9,134.9,138.2,146.9,155.6,162.2,165.2,169.2,174.5,180.5,186.5,189.5,193.5,201.5,210.2,218.9,222.9,228.9,231.9,234.9,238.9,249.5,255.5,259.5,264.9,270.9,276.9,282.2,286.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">pression of iNOS and COX-2. Moreover, </text>
  <text svgx:width="0.61,0.61,0.72,0.25,0.55,0.33,0.44,0.5,0.5,0.44,0.44,0.5,0.25,0.55,0.61,0.56,0.56,0.33,0.28,0.5,0.5,0.5,0.44,0.44,0.5,0.25,0.55,0.61,0.72,0.56,0.33,0.52,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.61,0.33,0.5,0.25" y="620.5" x="70.9,78.2,85.6,94.2,97.2,98.8,102.8,108.1,114.1,120.1,125.4,130.7,136.7,139.7,141.3,148.6,155.3,162.0,166.0,169.3,175.3,181.3,187.3,192.6,197.9,203.9,206.9,208.5,215.8,224.5,231.1,235.1,241.4,244.4,246.0,251.3,257.3,263.3,266.3,267.9,271.9,279.2,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">LEO reduced LPS-induced TNF-α and IL-6 </text>
  <text svgx:width="0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.72,0.28,0.5,0.44,0.33,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.5,0.44,0.5,0.44,0.25,0.55,0.39,0.28,0.78,0.28,0.28,0.44,0.33,0.28,0.5,0.25,0.55,0.33,0.44,0.33" y="634.3" x="70.9,76.9,80.9,86.9,92.9,98.9,104.3,107.6,110.9,116.9,122.9,125.9,128.9,130.7,139.4,142.7,148.7,154.1,158.0,161.0,162.8,167.5,170.8,176.8,182.8,186.2,191.5,196.2,199.2,200.9,207.0,212.3,218.3,223.6,226.6,228.4,233.1,236.4,245.7,249.0,252.4,257.7,261.7,265.1,271.1,274.1,275.8,279.9,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">production. Other studies have similarly re-</text>
  <text svgx:width="0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.5,0.33,0.25,0.44,0.39,0.33" y="648.1" x="70.9,76.9,82.9,86.9,90.3,95.6,101.6,104.3,107.7,113.7,119.0,122.3,125.0,128.4,134.4,139.7,142.4,147.8,153.8,157.1,160.5,164.4,167.8,173.8,177.7,181.1,186.4,195.7,205.1,210.4,213.8,219.8,223.8,229.8,232.5,237.8,241.8,245.8,251.1,256.5,259.8,262.5,268.5,272.5,275.2,280.5,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ported that the anti-inflammatory effect of es-</text>
  <text svgx:width="0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.5,0.28,0.28,0.39,0.25,0.28,0.39,0.25,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25,0.72,0.28,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25" y="661.9" x="70.9,75.6,80.9,86.9,90.3,93.6,98.9,102.3,105.5,111.5,114.9,118.2,122.9,126.1,129.5,134.1,137.4,142.7,147.4,152.1,158.1,163.4,166.7,172.1,175.4,180.7,186.7,190.0,198.7,202.0,205.3,211.3,214.6,217.9,223.9,229.3,232.5,237.2,243.2,249.2,255.2,259.2,264.5,269.2,273.9,277.2,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">sential oils is associated with the suppression </text>
  <text svgx:width="0.5,0.33,0.25,0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.33,0.39,0.25,0.39,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.56,0.72,0.61" y="675.7" x="70.9,76.9,80.9,83.6,92.8,98.2,104.2,107.5,112.9,116.2,122.2,126.2,130.9,133.6,138.2,144.2,149.6,155.6,158.2,163.6,168.3,170.9,177.6,186.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">of mediators such as PGE</text>
  <text svgx:width="0.5" y="676.1" x="193.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2</text>
  <text svgx:width="0.25,0.25,0.72,0.72,0.25,0.25,0.33,0.61,0.33,0.5,0.25,0.25,0.61,0.72,0.56,0.33,0.52,0.25,0.25" y="675.7" x="197.6,200.6,203.2,211.9,220.5,223.5,226.2,230.2,237.5,241.5,247.5,250.5,253.1,260.5,269.1,275.8,279.8,286.1,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, NO, IL-6, TNF-α, </text>
  <text svgx:width="0.67,0.72,0.72,0.33,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.28,0.72,0.72,0.56,0.25,0.33,0.72,0.5,0.5,0.5,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.25,0.5,0.5,0.5,0.5,0.44,0.25,0.25,0.5,0.33,0.25,0.25,0.25" y="689.5" x="70.9,78.9,87.6,96.3,100.3,106.3,109.3,112.3,117.6,123.6,129.6,132.6,135.9,144.6,153.3,159.9,162.9,166.9,175.6,181.6,187.6,193.6,196.6,201.9,205.3,208.3,213.6,216.9,219.9,223.0,225.9,231.9,238.0,244.0,250.0,255.3,258.3,261.3,267.3,271.3,274.3,277.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">COX-2, and iNOS (Yoon et al., 2010a, b). </text>
  <text svgx:width="0.89,0.72,0.56,0.72,0.39,0.25,0.44,0.33,0.44,0.25,0.28,0.5,0.44,0.25,0.78,0.44,0.28,0.5,0.33,0.25,0.44,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.39,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25" y="703.3" x="88.8,99.5,108.1,114.8,123.5,128.2,131.7,137.0,141.0,146.4,149.9,153.2,159.2,164.6,168.1,177.3,182.7,186.0,192.0,196.0,199.6,204.9,210.9,220.2,226.2,232.2,238.2,243.5,249.5,252.8,257.5,261.0,267.0,271.0,274.5,277.9,283.9,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">MAPKs are the major components of the </text>
  <text svgx:width="0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.28,0.44,0.44,0.5,0.39,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25" y="717.1" x="70.9,75.6,78.9,84.9,90.9,96.3,99.6,103.0,109.0,115.0,117.5,123.6,128.9,132.2,138.2,146.9,152.2,158.2,160.8,164.2,170.2,175.5,178.8,181.4,184.8,190.1,195.4,201.4,206.1,208.7,212.0,218.0,220.6,223.9,230.0,235.3,237.9,243.2,249.2,255.2,259.2,264.5,269.2,273.9,277.2,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">signaling pathway that leads to the expression </text>
  <text svgx:width="0.5,0.33,0.25,0.55,0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.33,0.39,0.25,0.25,0.89,0.5,0.33,0.44,0.5,0.5,0.44,0.33,0.25,0.25,0.28,0.28,0.25" y="730.9" x="70.9,76.9,80.9,83.9,84.8,90.8,94.8,100.8,104.8,108.1,114.1,118.1,121.5,126.8,136.1,145.4,150.8,154.1,160.1,164.1,170.1,173.1,174.0,183.3,188.7,194.7,198.1,203.4,206.7,212.7,216.7,221.4,224.4,228.3,239.0,245.0,249.0,254.3,260.3,266.3,271.7,275.7,278.7,282.5,285.9,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">of pro-inflammatory mediators. Moreover, it </text>
  <text svgx:width="0.28,0.39,0.25,0.5,0.5,0.5,0.72,0.5,0.25,0.28,0.5,0.44,0.28,0.25,0.89,0.72,0.56,0.72,0.39,0.25,0.5,0.28,0.44,0.5,0.25,0.44,0.5,0.25,0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25,0.33,0.5,0.28,0.44,0.25" y="744.7" x="70.9,74.3,78.9,82.2,88.2,94.2,100.2,108.9,114.9,118.2,121.5,127.5,132.8,136.2,139.5,150.1,158.8,165.5,174.1,178.8,182.1,188.1,191.4,196.8,202.7,206.0,211.4,217.4,220.6,224.0,233.2,239.2,245.2,249.2,252.6,257.9,263.9,267.3,270.6,274.6,280.6,283.9,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">is known that MAPKs play an important role </text>
  <text svgx:width="0.28,0.5,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.61,0.56,0.56,0.33,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25" y="758.5" x="70.9,74.3,80.3,83.3,84.2,87.5,93.5,97.5,100.8,106.2,115.5,124.8,130.2,133.5,139.5,143.5,149.5,152.5,153.4,158.1,161.4,167.4,173.4,178.7,182.1,185.4,191.3,197.3,200.3,201.2,204.6,210.6,213.6,214.5,221.8,228.5,235.2,239.2,243.9,247.2,250.5,259.9,265.9,269.2,274.6,277.9,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">in inflammatory signaling in LPS-stimulated </text>
  <text svgx:width="0.78,0.44,0.44,0.33,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.55,0.33,0.72,0.5,0.78,0.78,0.44,0.39,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.72,0.44,0.5,0.44,0.5,0.5,0.25" y="96.1" x="306.1,315.4,320.7,326.0,330.0,336.0,342.1,348.1,353.4,359.4,364.7,369.4,372.4,373.3,377.3,386.0,392.0,401.3,410.6,415.9,420.7,423.7,424.6,429.9,433.3,436.3,437.2,442.5,445.9,448.9,451.9,454.9,455.8,461.8,467.8,473.8,479.8,483.1,486.1,487.1,495.7,501.1,507.1,512.4,518.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">macrophages (Hommes et al., 2003; Nakano </text>
  <text svgx:width="0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.56,0.5,0.33,0.28,0.5,0.44,0.33,0.78,0.5,0.33,0.44,0.25,0.25,0.5,0.5,0.5,0.25,0.28,0.39,0.25,0.28,0.5,0.5,0.5,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25" y="109.9" x="306.1,311.5,314.8,318.2,323.5,326.8,329.8,332.8,336.2,342.2,348.2,354.2,360.2,364.2,367.2,370.6,377.3,383.3,387.3,390.6,396.6,401.9,405.9,415.2,421.2,425.2,430.5,433.5,436.9,442.9,448.9,454.9,458.3,461.6,466.3,469.6,473.0,479.0,485.0,491.0,494.3,500.3,505.7,511.7,515.0,518.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">et al., 1998). Furthermore, p38 is involved in </text>
  <text svgx:width="0.28,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.5,0.39,0.44,0.33,0.28,0.5,0.28,0.28,0.5,0.5,0.44,0.28,0.25,0.55,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.33" y="123.7" x="306.1,309.5,315.5,320.8,323.8,325.9,329.3,333.3,338.6,344.6,349.3,354.6,358.6,361.9,367.9,371.3,374.6,380.6,386.6,391.9,395.3,398.3,400.4,404.3,409.7,415.7,421.6,424.9,430.2,433.6,436.9,442.9,448.9,451.9,454.0,460.0,464.0,467.0,469.1,475.1,479.1,485.1,489.1,492.4,498.4,502.4,505.8,511.1,520.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">the transcriptional regulation of pro-inflam-</text>
  <text svgx:width="0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.33,0.39,0.25,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.72,0.72,0.56,0.25,0.25,0.55,0.67,0.72,0.72,0.33,0.5,0.25,0.25" y="137.5" x="306.1,315.4,320.7,324.1,330.1,334.1,340.1,343.1,345.1,354.3,359.7,365.7,369.0,374.4,377.7,383.6,387.7,392.3,395.4,398.4,400.3,403.7,409.7,415.0,418.3,424.3,430.3,433.6,439.6,445.7,448.7,450.7,454.0,462.7,471.3,478.0,481.0,484.0,486.0,494.1,502.7,511.4,515.4,521.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">matory mediators, including iNOS, COX-2, </text>
  <text svgx:width="0.44,0.5,0.5,0.25,0.55,0.61,0.72,0.56,0.33,0.52,0.25,0.25,0.55,0.28,0.5,0.25,0.55,0.61,0.56,0.56,0.33,0.28,0.5,0.5,0.5,0.44,0.44,0.5,0.25,0.55,0.78,0.44,0.44,0.33,0.5,0.5,0.5,0.44,0.5,0.44,0.25,0.55,0.33,0.44,0.33" y="151.3" x="306.1,311.4,317.4,323.4,326.4,327.6,335.0,343.6,350.3,354.3,360.6,363.6,366.6,367.8,371.1,377.2,380.2,381.4,388.7,395.4,402.0,406.0,409.4,415.4,421.4,427.4,432.7,438.1,444.1,447.1,448.3,457.5,462.9,468.2,472.2,478.2,484.2,490.2,495.5,501.5,506.9,509.9,511.1,515.1,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and TNF-α, in LPS-induced macrophage re-</text>
  <text svgx:width="0.39,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.55,0.33,0.67,0.5,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.33,0.5,0.25,0.55,0.44,0.5,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.25,0.55,0.28,0.5,0.44,0.25" y="165.1" x="306.1,310.8,316.8,322.8,328.8,333.5,338.8,343.5,346.5,348.2,352.2,360.2,366.2,371.5,374.9,377.9,379.5,384.9,388.2,391.2,392.9,398.2,401.6,404.6,407.6,410.6,412.3,418.3,424.3,430.3,436.3,440.3,443.3,446.3,448.0,452.0,458.0,461.0,462.7,468.0,474.0,480.0,483.4,486.7,490.0,496.1,502.1,505.1,508.1,509.7,513.1,519.1,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">sponses (Bhat et al., 1998). In addition, the </text>
  <text svgx:width="0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.61,0.67,0.72,0.25,0.28,0.39,0.25,0.28,0.5,0.5,0.5,0.5,0.5,0.28,0.25,0.28,0.5,0.25,0.5,0.44,0.25,0.28,0.78,0.33" y="178.9" x="306.1,312.1,318.1,324.1,328.8,334.8,340.8,346.8,350.8,356.8,360.1,365.5,368.8,372.2,378.2,384.2,387.6,393.6,397.6,401.1,408.4,416.4,425.1,428.6,431.9,436.6,440.0,443.4,449.4,455.4,461.4,467.4,473.4,476.7,480.2,483.5,489.5,493.0,499.0,504.3,507.8,511.1,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">phosphorylation of ERK is thought to be im-</text>
  <text svgx:width="0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.28,0.5,0.44,0.33,0.44,0.44,0.39,0.44,0.5,0.25,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.5,0.33,0.5,0.33,0.28,0.5,0.33" y="192.7" x="306.1,312.1,315.5,318.8,324.1,329.5,332.8,338.1,344.1,346.8,350.1,356.1,358.7,362.1,368.1,373.4,376.0,379.4,385.4,390.7,394.7,400.0,405.4,409.9,415.2,421.2,423.9,429.9,433.8,439.8,445.8,451.8,457.2,460.5,463.8,469.8,475.8,478.4,484.4,488.4,491.0,497.0,501.0,507.0,511.0,514.3,520.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">plicated in the increased production of pro-in-</text>
  <text svgx:width="0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.72,0.72,0.56,0.25,0.55,0.28,0.5,0.25,0.55,0.61,0.56,0.56,0.33,0.28,0.5,0.33" y="206.5" x="306.1,310.1,313.5,318.8,328.1,337.5,342.8,346.1,352.1,356.1,362.1,365.1,367.0,372.3,378.3,381.6,387.6,393.6,397.0,403.0,408.3,413.0,416.0,417.8,423.2,429.2,435.2,438.2,440.0,443.4,452.0,460.7,467.4,470.4,472.2,475.5,481.5,484.5,486.4,493.7,500.4,507.1,511.1,514.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">flammatory cytokines and iNOS in LPS-in-</text>
  <text svgx:width="0.5,0.5,0.44,0.44,0.5,0.25,0.55,0.78,0.44,0.44,0.33,0.5,0.5,0.5,0.44,0.5,0.44,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.55,0.33,0.72,0.28,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25" y="220.3" x="306.1,312.1,318.1,323.5,328.8,334.8,337.8,339.1,348.4,353.7,359.0,363.0,369.0,375.0,381.0,386.4,392.4,397.7,400.7,402.0,406.0,411.4,416.0,422.0,428.0,434.1,438.7,444.1,448.7,451.7,453.1,457.1,465.7,469.1,472.4,477.7,481.1,486.4,492.4,495.4,496.7,502.1,505.4,508.4,509.7,515.1,518.4,521.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">duced macrophage responses (Ajizian et al., </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.67,0.5,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.72,0.28,0.5,0.44,0.33,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.55,0.5,0.44,0.5,0.44,0.25" y="234.1" x="306.1,312.1,318.1,324.1,330.1,333.5,336.5,337.8,345.9,351.9,357.2,360.5,363.5,364.9,370.2,373.6,376.6,377.9,383.3,386.6,389.6,392.6,395.6,397.0,403.0,409.0,415.0,421.0,424.9,427.9,430.9,432.3,441.0,444.3,450.3,455.7,459.7,462.7,464.0,468.7,472.0,478.1,484.1,487.4,492.7,497.4,500.4,501.8,507.8,513.1,519.1,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1999; Bhat et al., 1998). Other studies have </text>
  <text svgx:width="0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.39,0.72,0.72,0.25,0.55,0.28,0.39,0.25,0.55,0.5,0.33,0.28,0.78,0.44,0.33,0.28,0.28,0.5,0.25,0.55,0.28,0.78,0.5,0.28,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25" y="247.9" x="306.1,310.1,315.5,321.5,327.5,331.5,334.8,340.2,346.2,349.2,350.4,353.8,359.8,365.1,368.4,371.4,372.7,377.4,386.1,394.7,397.7,399.0,402.3,407.0,410.0,411.3,417.3,421.3,424.6,433.9,439.2,443.2,446.6,449.9,455.9,458.9,460.2,463.5,472.8,478.8,482.1,485.5,490.8,496.1,499.5,504.8,510.8,513.8,515.1,518.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">reported that JNK is primarily implicated in </text>
  <text svgx:width="0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.72,0.72,0.56,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.72,0.72,0.33,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.61,0.56,0.56,0.33" y="261.7" x="306.1,309.5,315.5,320.8,323.8,324.8,330.1,336.1,342.1,346.1,351.5,356.1,360.8,364.2,370.2,376.2,379.2,380.2,386.2,390.2,393.2,394.2,397.5,406.2,414.9,421.5,424.5,425.6,430.9,436.9,442.9,445.9,446.9,454.9,463.6,472.3,476.3,482.3,485.3,486.3,489.6,495.6,498.6,499.6,507.0,513.7,520.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">the expression of iNOS and COX-2 in LPS-</text>
  <text svgx:width="0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.78,0.44,0.44,0.33,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.55,0.33,0.67,0.5,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.28,0.44,0.5,0.44,0.39,0.25,0.25" y="275.5" x="306.1,310.8,314.1,317.5,326.7,332.7,336.1,341.4,344.8,350.1,356.1,359.1,361.7,371.0,376.3,381.7,385.7,391.7,397.7,403.7,409.0,415.0,420.4,425.0,428.0,430.7,434.7,442.7,448.7,454.1,460.1,463.1,465.7,471.0,477.0,483.1,486.1,488.7,496.7,500.0,505.4,511.4,516.7,521.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">stimulated macrophages (Chan and Riches, </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.72,0.28,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.61,0.5,0.44,0.33,0.44,0.33,0.5,0.33,0.44,0.25,0.25,0.55,0.72,0.44,0.25,0.55,0.44,0.39,0.33" y="289.3" x="306.1,312.1,318.1,324.1,330.1,333.5,336.5,339.2,347.9,351.2,357.2,360.2,363.0,368.3,371.7,374.7,377.4,382.8,386.1,389.1,392.1,395.1,397.9,403.9,409.9,415.9,421.9,425.9,428.9,431.9,434.6,442.0,448.0,453.3,457.3,462.6,466.6,472.6,476.6,482.0,485.0,488.0,490.7,499.4,504.7,507.7,510.5,515.8,520.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1998; Uto et al., 2005). Therefore, we as-</text>
  <text svgx:width="0.39,0.44,0.39,0.39,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.89,0.72,0.56,0.72,0.25,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.28,0.5,0.44,0.28,0.33" y="303.1" x="306.1,310.8,316.1,320.8,325.5,330.8,336.8,339.6,343.0,349.0,354.3,357.1,367.8,376.5,383.1,391.8,394.6,399.3,402.6,408.6,414.6,420.0,423.3,426.6,432.7,438.7,441.5,447.5,452.8,456.2,462.2,470.8,476.2,482.2,485.0,488.3,494.3,497.1,502.5,505.8,511.8,517.1,520.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">sessed the MAPK signaling pathway to eluci-</text>
  <text svgx:width="0.5,0.44,0.28,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.78,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.78,0.25,0.55,0.5,0.5,0.5,0.44,0.33,0.28,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33" y="316.9" x="306.1,312.1,317.5,320.8,326.1,329.1,331.5,334.9,340.9,346.2,349.2,351.6,360.8,366.2,371.6,377.6,382.9,388.9,392.3,396.9,406.2,409.2,411.6,417.6,423.6,429.6,434.9,438.9,442.3,448.3,451.6,457.6,463.6,466.6,469.0,472.3,478.3,483.7,486.7,489.1,494.4,500.4,503.8,507.1,511.1,514.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">date the mechanism underlying the anti-in-</text>
  <text svgx:width="0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.61,0.61,0.72,0.25,0.55,0.28,0.5,0.25,0.55,0.61,0.56,0.56,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25" y="330.7" x="306.1,310.1,313.4,318.8,328.1,337.5,342.8,346.2,352.2,356.2,362.2,365.2,367.0,372.4,376.3,380.3,385.6,391.0,394.3,397.3,399.2,405.2,409.2,412.2,414.0,421.4,428.7,437.4,440.4,442.2,445.6,451.6,454.6,456.4,463.8,470.5,477.1,481.2,486.5,491.8,495.2,498.5,504.5,509.8,513.1,518.5,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">flammatory effect of LEO in LPS-activated </text>
  <text svgx:width="0.78,0.44,0.44,0.33,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.33,0.44,0.39,0.5,0.28,0.28,0.39,0.25,0.55,0.39,0.5,0.5,0.72,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.5,0.33,0.44,0.33" y="344.5" x="306.1,315.4,320.7,326.0,330.0,336.0,342.1,348.1,353.4,359.4,364.7,369.4,372.4,375.4,378.0,385.3,391.3,396.7,399.7,402.3,406.3,411.6,416.3,422.3,425.6,429.0,433.6,436.6,439.2,443.9,449.9,455.9,464.6,469.9,475.9,478.9,481.5,484.8,490.9,496.2,499.5,502.5,505.1,511.1,515.1,520.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">macrophages. The results showed that pre-</text>
  <text svgx:width="0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.72,0.28,0.28,0.5,0.25,0.55,0.61,0.61,0.72,0.25,0.55,0.33,0.44,0.39,0.5,0.28,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.44,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.33,0.28,0.44,0.44,0.5,0.28,0.25" y="358.3" x="306.1,309.5,313.5,318.8,324.1,327.4,336.7,342.0,348.0,351.4,354.4,355.5,364.2,367.5,370.9,376.9,379.9,381.0,388.4,395.7,404.4,407.4,408.5,412.5,417.9,422.5,428.6,431.9,435.2,440.6,446.6,449.6,450.7,454.1,460.1,463.1,464.2,469.6,472.6,473.7,478.4,481.7,487.7,493.7,497.1,501.1,504.4,509.8,515.1,521.1,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">treatment with LEO resulted in a significant </text>
  <text svgx:width="0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.39,0.72,0.72,0.25,0.25,0.61,0.67,0.72,0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.5,0.5,0.25,0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.33" y="372.1" x="306.1,310.8,316.8,322.8,328.8,332.8,338.1,342.8,347.5,350.8,356.8,362.8,365.4,371.4,375.4,378.0,382.7,391.3,400.0,403.0,405.6,412.9,420.9,429.6,432.6,435.2,440.5,446.5,452.5,455.1,461.1,467.1,473.1,475.7,481.7,487.7,493.7,498.4,504.4,510.4,516.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">suppression of JNK, ERK, and p38 phosphor-</text>
  <text svgx:width="0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.61,0.56,0.56,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.78,0.44,0.44,0.33,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.25" y="385.9" x="306.1,312.1,315.5,320.8,324.1,327.5,333.5,339.5,342.5,345.8,351.8,354.8,358.2,364.2,369.5,372.5,379.8,386.5,393.2,397.2,402.5,407.8,411.2,414.5,420.5,425.8,429.2,434.5,440.5,443.5,452.8,458.1,463.4,467.4,473.4,479.4,485.4,490.8,496.8,502.1,506.8,509.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ylation in the LPS-activated macrophages. </text>
  <text svgx:width="0.72,0.56,0.33,0.5,0.67,0.25,0.28,0.39,0.25,0.44,0.25,0.78,0.44,0.78,0.78,0.44,0.28,0.28,0.44,0.5,0.25,0.28,0.33,0.44,0.5,0.39,0.44,0.33,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.33,0.44,0.44,0.33" y="399.7" x="324.0,332.6,339.3,343.3,349.4,357.4,360.9,364.3,369.0,372.5,377.8,381.4,390.6,396.0,405.4,414.7,420.0,423.4,426.7,432.1,438.1,441.6,445.0,449.0,454.3,460.3,465.0,470.3,474.3,477.6,483.6,486.9,490.3,496.3,502.2,505.8,509.7,515.1,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">NF-κB is a mammalian transcription fac-</text>
  <text svgx:width="0.28,0.5,0.33,0.25,0.28,0.5,0.44,0.28,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.44,0.39,0.25,0.78,0.44,0.5,0.5,0.25,0.5,0.44,0.5,0.44,0.39,0.25,0.25,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.5,0.39,0.44,0.25" y="413.5" x="306.1,309.5,315.5,319.5,322.1,325.5,331.5,336.8,340.1,342.8,346.8,352.1,358.1,364.1,367.5,372.8,376.2,381.5,386.2,388.8,398.1,403.4,409.4,415.4,418.0,424.1,429.4,435.4,440.7,445.4,448.4,451.1,454.4,460.4,465.7,469.1,475.1,481.1,484.4,490.4,496.5,499.1,502.4,508.4,514.5,519.1,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">tor that regulates many genes, including those </text>
  <text svgx:width="0.28,0.5,0.5,0.5,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.72,0.72,0.56,0.25,0.25,0.55,0.67,0.72,0.72,0.33,0.5,0.25,0.25" y="427.3" x="306.1,309.5,315.5,321.5,327.5,330.8,336.8,342.2,348.2,351.2,354.5,357.8,363.8,369.2,372.2,375.5,380.8,386.8,392.8,396.8,402.1,406.8,411.5,414.8,420.8,426.8,429.8,433.1,439.1,443.1,446.1,449.4,452.8,461.5,470.1,476.8,479.8,482.8,486.1,494.1,502.8,511.5,515.5,521.5,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">involved the expression of iNOS, COX-2, </text>
  <text svgx:width="0.61,0.72,0.56,0.33,0.52,0.25,0.25,0.33,0.61,0.33,0.5,0.51,0.25,0.25,0.44,0.5,0.5,0.25,0.33,0.61,0.33,0.5,0.25,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.44,0.33,0.44,0.25,0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25" y="441.1" x="306.1,313.4,322.1,328.7,332.8,339.1,342.1,345.3,349.3,356.7,360.7,366.7,372.8,375.8,379.0,384.4,390.4,396.4,399.6,403.6,410.9,414.9,421.0,424.0,427.2,435.9,441.9,445.2,450.5,456.5,459.8,465.1,469.1,474.5,477.7,481.0,490.4,496.4,502.4,506.4,509.7,515.1,521.1,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">TNF-α, IL-1β, and IL-6, which are important </text>
  <text svgx:width="0.28,0.5,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.55,0.28,0.5,0.25" y="454.9" x="306.1,309.5,315.5,318.5,321.7,325.0,334.3,343.6,349.6,355.6,360.9,363.9,367.1,372.5,378.5,384.5,387.5,390.7,394.0,400.0,404.0,407.4,412.7,422.0,431.3,436.6,440.0,446.0,450.0,456.0,459.0,462.2,466.2,471.5,476.2,482.2,488.2,494.2,498.9,504.2,508.9,511.9,515.1,518.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">in immune and inflammatory responses in </text>
  <text svgx:width="0.61,0.56,0.56,0.33,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.78,0.44,0.44,0.33,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.55,0.33,0.67,0.44,0.33,0.5,0.44,0.39,0.25,0.55,0.44,0.5,0.5,0.25" y="468.7" x="306.1,313.5,320.1,326.8,330.8,335.5,338.9,342.2,351.5,357.5,360.8,366.1,369.5,374.8,380.8,383.8,389.4,398.6,403.9,409.3,413.3,419.3,425.3,431.3,436.7,442.7,448.0,452.7,455.7,461.2,465.2,473.2,478.6,482.6,488.6,493.9,498.6,501.6,507.1,512.5,518.5,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">LPS-stimulated macrophages (Barnes and </text>
  <text svgx:width="0.72,0.44,0.33,0.28,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.33,0.5,0.25,0.5,0.5,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.72,0.56,0.33,0.5,0.67,0.25,0.28,0.39,0.25" y="482.5" x="306.1,314.8,320.1,324.1,327.5,333.5,336.5,339.6,345.6,351.6,357.6,363.6,367.6,370.6,373.7,377.7,383.7,386.8,392.8,398.8,403.5,406.9,410.2,419.4,425.4,428.8,434.1,437.5,442.8,448.8,451.9,457.2,462.6,465.9,469.2,473.9,476.9,480.0,488.6,495.3,499.2,505.3,513.3,516.4,519.7,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Karin, 1997). In unstimulated cells, NF-κB is </text>
  <text svgx:width="0.5,0.33,0.44,0.39,0.44,0.5,0.28,0.25,0.55,0.44,0.39,0.25,0.55,0.44,0.25,0.55,0.5,0.5,0.28,0.44,0.39,0.44,0.44,0.5,0.28,0.25,0.55,0.33,0.5,0.33,0.78,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.5,0.33" y="496.3" x="306.1,312.1,316.1,321.5,326.2,331.5,337.5,340.9,343.9,344.9,350.2,354.9,357.9,358.9,364.2,367.2,368.3,374.3,380.3,383.6,389.0,393.7,399.0,404.3,410.3,413.7,416.7,417.7,421.6,427.6,431.6,440.9,443.9,444.9,450.9,456.9,462.9,468.9,474.9,477.9,479.0,482.3,488.3,491.3,492.3,495.7,501.7,507.0,510.0,511.0,514.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">present as a quiescent form bound to the in-</text>
  <text svgx:width="0.5,0.28,0.5,0.28,0.28,0.5,0.33,0.5,0.25,0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.33,0.5,0.67,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.5,0.39,0.5,0.28,0.25,0.33,0.72,0.44,0.33,0.28,0.5,0.25,0.44,0.5,0.5,0.25" y="510.1" x="306.1,312.1,315.5,321.5,324.8,328.1,334.1,338.1,344.1,347.1,353.1,357.1,363.1,366.5,371.8,375.1,381.1,384.1,388.1,394.1,402.2,405.1,408.5,414.5,417.5,420.8,426.8,432.1,435.1,440.4,446.5,449.8,455.8,460.5,466.4,469.8,472.8,476.8,485.3,490.7,494.7,498.0,504.1,507.0,512.4,518.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">hibitory protein IκB in the cytosol (Karin and </text>
  <text svgx:width="0.67,0.44,0.5,0.33,0.72,0.44,0.33,0.28,0.44,0.5,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.72,0.5,0.5,0.5,0.25,0.55,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.72,0.28,0.28,0.5,0.25" y="523.9" x="306.1,314.1,319.5,325.5,329.5,338.1,343.5,347.5,350.8,356.1,362.1,365.2,368.2,371.7,377.7,383.7,389.7,395.7,399.7,402.7,405.7,409.3,417.9,423.9,429.9,435.9,438.9,442.5,447.2,450.5,453.8,463.1,469.1,472.4,477.8,481.1,484.4,490.4,496.4,499.4,503.0,511.7,515.0,518.3,524.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Ben-Neriah, 2000). Upon stimulation with </text>
  <text svgx:width="0.61,0.56,0.56,0.25,0.25,0.33,0.5,0.67,0.25,0.28,0.39,0.25,0.5,0.44,0.5,0.33,0.44,0.5,0.44,0.5,0.25,0.25,0.72,0.5,0.28,0.44,0.5,0.25,0.5,0.44,0.33,0.78,0.28,0.28,0.39,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.33" y="537.7" x="306.1,313.4,320.1,326.8,329.8,333.4,337.4,343.5,351.5,355.2,358.5,363.2,366.8,372.8,378.2,384.2,388.2,393.5,399.5,404.9,410.9,413.9,417.5,426.1,432.1,435.4,440.8,446.8,450.4,456.4,461.8,465.8,475.0,478.4,481.7,486.4,490.0,493.4,499.4,504.7,508.4,514.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">LPS, IκB is degraded, which permits the nu-</text>
  <text svgx:width="0.44,0.28,0.44,0.44,0.33,0.25,0.55,0.28,0.33,0.44,0.5,0.39,0.28,0.5,0.44,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.56,0.33,0.5,0.67,0.25,0.55,0.44,0.5,0.78,0.5,0.28,0.44,0.5,0.25,0.25" y="551.5" x="306.1,311.4,314.8,320.1,325.4,329.4,332.4,335.6,338.9,342.9,348.2,354.2,358.9,362.2,368.2,373.6,378.9,382.2,385.6,391.6,397.6,400.6,403.7,409.7,413.7,416.7,419.8,423.1,429.1,434.5,437.5,440.6,449.3,455.9,459.9,466.0,474.0,477.0,480.1,485.4,491.4,500.7,506.7,510.0,515.4,521.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">clear translocation of the NF-κB complex, </text>
  <text svgx:width="0.72,0.5,0.44,0.33,0.44,0.25,0.28,0.28,0.25,0.5,0.28,0.5,0.5,0.39,0.25,0.5,0.5,0.25,0.39,0.28,0.28,0.44,0.39,0.25,0.44,0.5,0.5,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.39,0.25,0.28,0.5,0.44,0.25,0.5,0.44,0.5,0.44,0.25" y="565.3" x="306.1,314.8,320.8,326.1,330.1,335.5,338.8,342.1,345.5,348.8,354.8,358.1,364.0,370.0,374.7,378.0,384.0,390.0,393.3,398.0,401.3,404.7,410.0,414.7,418.0,423.3,429.3,435.3,438.6,443.9,449.2,452.6,455.9,461.9,467.2,470.6,475.9,480.6,483.8,487.2,493.2,498.5,501.8,507.8,513.1,519.1,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">where it binds kb sites and activates the gene </text>
  <text svgx:width="0.28,0.33,0.44,0.5,0.39,0.44,0.33,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.72,0.72,0.56,0.25,0.25,0.67,0.72,0.72,0.33,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.5,0.44,0.33,0.25,0.5,0.33,0.5,0.33" y="579.1" x="306.1,309.5,313.5,318.8,324.8,329.4,334.8,338.8,342.1,348.1,351.4,354.8,360.8,366.8,369.6,375.6,379.6,382.4,385.8,394.4,403.1,409.8,412.8,415.6,423.6,432.2,440.9,444.9,450.9,453.9,456.7,462.0,468.0,474.0,476.9,482.9,486.2,492.2,497.5,501.5,504.3,510.3,514.3,520.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">transcription of iNOS, COX-2, and other pro-</text>
  <text svgx:width="0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.33,0.56,0.5,0.33,0.5,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.33,0.5,0.25" y="592.9" x="306.1,309.5,315.5,319.5,322.8,328.1,337.5,346.7,352.1,355.4,361.4,365.5,371.5,374.1,379.5,385.5,388.8,394.8,400.8,404.2,410.2,415.5,420.2,422.8,426.8,433.5,439.5,443.5,449.5,452.1,457.5,460.8,463.5,468.8,472.1,475.1,478.1,480.8,486.8,492.8,498.8,504.8,508.8,511.8,514.4,518.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">inflammatory cytokines (Surh et al., 2001). In </text>
  <text svgx:width="0.5,0.5,0.33,0.25,0.55,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.25,0.55,0.61,0.61,0.72,0.25,0.55,0.44,0.28,0.28,0.44,0.5,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.33,0.5,0.67,0.33,0.52,0.25,0.55,0.5,0.44,0.5,0.33,0.44,0.5,0.44,0.33" y="606.7" x="306.1,312.1,318.1,322.1,325.1,326.7,331.4,334.7,340.7,346.7,350.1,355.4,360.1,363.1,366.1,367.7,375.0,382.3,391.0,394.0,395.6,400.9,404.3,407.6,412.9,418.9,424.9,430.3,433.6,438.9,444.9,447.9,449.5,453.5,459.6,467.6,471.6,477.8,480.8,482.5,488.5,493.8,499.8,503.8,509.1,515.1,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">our studies, LEO attenuated IκB-α degrada-</text>
  <text svgx:width="0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.44,0.5,0.25,0.72,0.56,0.33,0.5,0.67,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.61,0.56,0.56,0.33" y="620.5" x="306.1,309.5,312.8,318.8,324.8,327.3,332.6,338.6,344.6,347.1,351.7,357.7,363.7,369.7,373.7,379.1,383.7,388.4,393.7,399.7,402.2,410.9,417.5,421.5,427.6,435.6,438.0,443.4,448.7,452.0,455.4,461.4,466.7,470.1,473.4,479.4,485.4,487.8,491.2,497.2,499.6,507.0,513.7,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">tion and suppressed NF-κB activation in LPS-</text>
  <text svgx:width="0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.67,0.72,0.94,0.5,0.5,0.5,0.25,0.5,0.25,0.55,0.44,0.44,0.28,0.28,0.39,0.25,0.25,0.55,0.61,0.5,0.28,0.39,0.25,0.55,0.39,0.5,0.5,0.5,0.44,0.39,0.28,0.39,0.25" y="634.3" x="306.1,310.8,314.1,317.5,326.7,332.7,336.1,341.4,344.7,350.1,356.1,359.1,362.6,370.6,379.3,390.6,396.6,402.7,408.7,411.7,417.7,420.7,424.2,429.5,434.9,438.2,441.6,446.2,449.2,452.2,455.8,463.1,469.1,472.5,477.1,480.1,483.7,488.4,494.4,500.4,506.4,511.7,516.4,519.7,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">stimulated RAW264.7 cells. This suggests </text>
  <text svgx:width="0.28,0.5,0.44,0.28,0.25,0.28,0.28,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.39,0.25,0.28,0.5,0.44,0.25,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25" y="648.1" x="306.1,309.5,315.5,320.8,324.2,327.5,330.9,334.2,337.6,340.9,346.9,352.9,356.3,362.2,365.5,368.9,373.6,376.9,380.3,386.3,391.6,395.0,400.3,405.7,409.0,412.3,418.4,423.6,426.9,430.3,436.3,442.3,445.7,451.7,455.6,459.0,462.3,468.4,472.3,475.7,481.0,490.4,499.7,505.1,508.4,514.4,518.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">that it inhibits the activation of inflammatory </text>
  <text svgx:width="0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.33,0.39,0.25,0.55,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.72,0.56,0.33,0.5,0.67,0.25,0.55,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25" y="661.9" x="306.1,315.4,320.7,326.7,330.1,335.4,338.7,344.7,348.7,353.4,356.4,358.4,364.4,370.4,373.4,375.3,381.3,384.7,390.7,396.0,402.0,405.4,411.4,417.4,420.4,422.3,425.7,431.7,437.0,440.0,442.0,450.7,457.3,461.3,467.4,475.4,478.4,480.4,485.1,488.4,494.4,500.4,505.7,509.1,512.4,518.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">mediators by blocking the NF-κB signaling </text>
  <text svgx:width="0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.25,0.55,0.5,0.5,0.33,0.28,0.5,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.78,0.44,0.44,0.33,0.5,0.33" y="675.7" x="306.1,312.1,317.5,320.8,326.8,335.5,340.8,346.8,349.8,354.9,360.9,366.9,370.9,374.2,380.2,386.2,389.2,394.3,397.6,403.6,409.0,412.0,417.0,422.3,427.7,431.0,434.4,440.4,445.7,449.0,452.4,458.4,464.4,467.4,472.4,478.4,482.4,485.4,490.5,499.7,505.1,510.4,514.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">pathway during the activation of macro-</text>
  <text svgx:width="0.5,0.5,0.44,0.5,0.44,0.39,0.25,0.25" y="689.5" x="306.1,312.1,318.1,323.4,329.4,334.8,339.4,342.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">phages. </text>
  <text svgx:width="0.33,0.5,0.25,0.55,0.44,0.5,0.5,0.44,0.28,0.5,0.39,0.28,0.5,0.5,0.25,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.44,0.33" y="703.3" x="324.0,328.0,334.0,337.0,338.7,344.0,350.0,356.0,361.4,364.7,370.7,375.3,378.7,384.6,390.6,393.6,396.6,398.3,401.7,407.7,413.0,416.0,417.7,423.0,429.0,432.4,435.7,439.7,443.1,449.1,453.0,456.4,461.7,471.0,480.4,485.7,489.1,495.1,499.1,505.1,508.1,509.8,515.1,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">In conclusion, the anti-inflammatory ac-</text>
  <text svgx:width="0.28,0.28,0.5,0.28,0.28,0.5,0.25,0.5,0.33,0.25,0.61,0.61,0.72,0.25,0.28,0.39,0.25,0.44,0.5,0.28,0.5,0.44,0.5,0.44,0.44,0.5,0.25,0.5,0.5,0.25,0.28,0.28,0.39,0.25,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25" y="717.1" x="306.1,309.5,312.8,318.8,322.1,325.5,331.5,334.3,340.3,344.3,347.2,354.5,361.9,370.5,373.4,376.8,381.4,384.3,389.6,395.6,399.0,405.0,410.3,416.3,421.6,426.9,432.9,435.8,441.8,447.8,450.7,454.0,457.4,462.0,464.9,468.2,474.2,480.2,483.6,489.6,492.9,496.2,499.6,505.6,511.6,514.5,520.5,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">tivity of LEO is evidenced by its inhibition of </text>
  <text svgx:width="0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.72,0.72,0.25,0.25,0.56,0.72,0.61" y="730.9" x="306.1,309.5,315.5,320.8,324.3,330.3,334.3,340.3,346.3,352.3,357.7,361.0,364.3,370.3,376.4,379.9,385.9,389.9,393.5,402.1,410.8,413.8,417.3,424.0,432.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">the production of NO, PGE</text>
  <text svgx:width="0.5" y="731.3" x="440.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2</text>
  <text svgx:width="0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.5,0.44,0.33,0.25,0.44,0.5,0.28,0.5,0.33" y="730.9" x="444.0,447.0,450.6,455.9,461.9,467.9,471.4,477.5,480.8,486.8,492.1,496.2,499.7,505.0,511.0,514.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, and other cyto-</text>
  <text svgx:width="0.5,0.28,0.5,0.44,0.39,0.25,0.33,0.44,0.25,0.5,0.25,0.25,0.25,0.61,0.72,0.56,0.33,0.52,0.25,0.44,0.5,0.5,0.25,0.33,0.61,0.33,0.5,0.33,0.25,0.5,0.28,0.44,0.25,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25" y="744.7" x="306.1,312.1,315.5,321.5,326.8,331.4,334.2,338.2,343.6,346.6,352.6,355.6,358.6,361.3,368.7,377.3,384.0,388.0,394.3,397.1,402.5,408.5,414.5,417.3,421.3,428.6,432.6,438.6,442.6,445.4,451.4,454.8,460.1,462.9,466.9,472.2,478.2,484.2,487.6,492.9,496.2,499.6,505.6,511.6,514.4,520.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">kines (e.g., TNF-α and IL-6) via regulation of </text>
 </g>
</svg>
